20 - 22 November, 2018 | Pullman Brussels Centre Midi Hotel, Brussels, Belgium

Resource Centre

Featured Content

Creating a Culture of Clinical Trial Inspection Readiness

When a culture of readiness is embedded within an organisation, the greatest level of inspection readiness can be maintained.We wanted to gain a greater understanding of the most important elements to consider when creating a culture of readiness including the training, documentation maintenance and vendor management during the clinical trial. In...

Sample Attendee List 2018

Ahead of GCP Inspection Readiness 2018 we have compiled a sample of this year's attendees. Take a look at who you can expect to meet, hear insights from and network with across the three-day event on the 20-22 November in Brussels, Belgium.If you would like more information about the event...

Market Report: Are you ready for your next Clinical Trial Inspection?

In the constantly evolving pharmaceutical regulatory environment, ongoing GCP inspection readiness is vital to ensure the successful launch of products. We wanted to understand where the industry is positioned in regard to inspection preparedness and the key pain points which are preventing the maintenance of a readiness culture within both...

Infographic: Top Tips for Clinical Trial Inspection Readiness

Preparing for an inspection can be very daunting, and extensive planning is critical to ensuring a smooth inspection experience. Organisations need to make sure they are aware of all the latest regulation and how their clinical trials are aligned to these. This handy infographic will look at the key elements...

What Lies Ahead for Clinical Data Management?

Collecting, storing and curating the vast quantities of scientific data in existence is not just important for regulatory submissions, but is also vital for ongoing pharma research and clinical trials. Carole L Palmer, a professor of library and information science at the University of Illinois, share her views on the matter and discussed the...

Past Presentation: Inspection Readiness during TMF Transformation - AstraZeneca

At the TMF and Inspection Readiness Forum 2017, AstraZeneca presented a session on 'Inspection Readiness during TMF Transformation'.Fill out the form below to download the presentation slides >>

Being Inspection Ready: Top Tips And Warnings

If you were handed with a notice for a clinical trial inspection plan right now, how would you react? - With a feeling of asserted confidence or a rush of slight concern? Wherever you think you would stand on this spectrum, use this infographic to learn from your peers’ mistakes. Pharma IQ invites...

EU Clinical trial Regulation: Producing plain language summaries

Producing simplified overviews of clinical studies for the general public isn’t as straightforward a proposition as it might seem. Pooja Phogat & Vidhi Vashisht of Kinapse set out the challenges.From 2019, pharmaceutical organisations will be expected to prepare plain-language summaries (PLSs) for all Phase 1–4 interventional trials, in line with...